Apellis Pharmaceuticals Inc

NASDAQ:APLS   3:59:56 PM EDT
46.48
-1.71 (-3.55%)
Other Pre-Announcement

Apellis Pharmaceuticals Reports First Quarter 2021 Financial Results

Published: 04/28/2021 21:55 GMT
Apellis Pharmaceuticals Inc (APLS) - Apellis Pharmaceuticals Reports First Quarter 2021 Financial Results.
Apellis Pharmaceuticals - Qtrly Loss per Share $2.32.
Apellis Pharmaceuticals - As of March 31, 2021, Had $723.7 Million in Cash, Equivalents, Short-term Marketable Securities.
Apellis Pharmaceuticals - Cash and Investments of $723.7 Million As of March 31, 2021 Support Cash Runway Into Second Half of 2022.